703 followers
RT @IUCTOncopoleICR: [Publication] @CIR_AACR ▶️ "Cibler le métabolisme des sphingolipides pour traiter les mélanomes" @crctoncopole @melasp…
329 followers
3,792 followers
Read about how #nSMase2 contributes to immune escape and how its reconstitution can augment immune infiltration and #ICB efficacy in #melanoma. @CordelierPierre @melasphinx https://t.co/NfX2kDapCa https://t.co/7DI0GKo7sG
57 followers
RT @IUCTOncopoleICR: [Publication] @CIR_AACR ▶️ "Cibler le métabolisme des sphingolipides pour traiter les mélanomes" @crctoncopole @melasp…
81 followers
RT @IUCTOncopoleICR: [Publication] @CIR_AACR ▶️ "Cibler le métabolisme des sphingolipides pour traiter les mélanomes" @crctoncopole @melasp…
3,792 followers
RT @IUCTOncopoleICR: [Publication] @CIR_AACR ▶️ "Neutral Sphingomyelinase 2 Heightens Anti-Melanoma Immune Responses and Anti–PD-1 Therapy…
144 followers
RT @IUCTOncopoleICR: [Publication] @CIR_AACR ▶️ "Neutral Sphingomyelinase 2 Heightens Anti-Melanoma Immune Responses and Anti–PD-1 Therapy…
3,546 followers
[Publication] @CIR_AACR ▶️ "Neutral Sphingomyelinase 2 Heightens Anti-Melanoma Immune Responses and Anti–PD-1 Therapy Efficacy" @crctoncopole @melasphinx 🔽 https://t.co/NMq6vaLqwd
3,792 followers
RT @IUCTOncopoleICR: [Publication] @CIR_AACR ▶️ "Cibler le métabolisme des sphingolipides pour traiter les mélanomes" @crctoncopole @melasp…
1,084 followers
RT @IUCTOncopoleICR: [Publication] @CIR_AACR ▶️ "Cibler le métabolisme des sphingolipides pour traiter les mélanomes" @crctoncopole @melasp…
3,546 followers
[Publication] @CIR_AACR ▶️ "Cibler le métabolisme des sphingolipides pour traiter les mélanomes" @crctoncopole @melasphinx 🔽 https://t.co/NMq6vaLqwd
747 followers
Neutral sphingomyelinase 2 heightens anti-melanoma immune responses and anti-PD-1 therapy efficacy https://t.co/D4eLrRmmUN
81 followers
Neutral sphingomyelinase 2 heightens anti-melanoma immune responses and anti-PD-1 therapy efficacy https://t.co/R45KoVbBb7
906 followers
New article: Neutral sphingomyelinase 2 heightens anti-melanoma immune responses and anti-PD-1 therapy efficacy https://t.co/uz8odNnsJC #melanoma #oncology https://t.co/qDjbuJjaXr
58 followers
RT @melasphinx: Neutral sphingomyelinase 2 heightens anti-melanoma immune responses and anti-PD-1 therapy efficacy https://t.co/J2VRlHahLU…
3,546 followers
RT @melasphinx: Neutral sphingomyelinase 2 heightens anti-melanoma immune responses and anti-PD-1 therapy efficacy https://t.co/J2VRlHahLU…
641 followers
RT @melasphinx: Neutral sphingomyelinase 2 heightens anti-melanoma immune responses and anti-PD-1 therapy efficacy https://t.co/J2VRlHahLU…
78 followers
RT @melasphinx: Neutral sphingomyelinase 2 heightens anti-melanoma immune responses and anti-PD-1 therapy efficacy https://t.co/J2VRlHahLU…
519 followers
Congratulations !
57 followers
RT @melasphinx: Neutral sphingomyelinase 2 heightens anti-melanoma immune responses and anti-PD-1 therapy efficacy https://t.co/J2VRlHahLU…
81 followers
Neutral sphingomyelinase 2 heightens anti-melanoma immune responses and anti-PD-1 therapy efficacy https://t.co/J2VRlHahLU @crctoncopole @IUCTOncopoleICR @CIR_AACR Delighted with this publication on #ceramide metabolism in #melanoma immunotherapy (#anti-